Lorazepam reduces recurrence of urethral obstruction in male cats a prospective, randomized, double-blinded, placebo-controlled study.
Clinical evidence update from Journal of the American Veterinary Medical Association
Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
A study published in Journal of the American Veterinary Medical Association in 2026 evaluated lorazepam reduces recurrence of urethral obstruction in male cats: a prospective, randomized, double-blinded, placebo-controlled study..
Key Findings
To determine the efficacy of lorazepam in reducing the rate of recurrence in first-time feline urethral obstruction (UO) and frequency of lower urinary tract (LUT) signs following hospitalization, as well as adverse effects of the medication. This was a prospective, randomized, double-blinded, placebo-controlled study of 80 client-owned male cats presenting to a university teaching hospital with UO between 2021 and 2025. Cats with urolithiasis or urinary tract infection were excluded. Cats received lorazepam or placebo for 1 month after hospitalization for UO. 41 cats received lorazepam and 39 cats received placebo. Seventy-two cats...
Why It Matters for Veterinary Professionals
For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.
Practical Interpretation
The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.
Clinical Takeaway
Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.
Read the full article here.
Comments
Related Articles
More news
Copyright © 2026 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment